Recent News for NBRV - Nabriva Therapeutics AG

Date Title
Jun 24 CONTEPO CRL Is a Blow for Cash-Strapped Nabriva (NBRV), Says Analyst
Jun 22 Is Nabriva Therapeutics plc (NBRV) A Good Stock To Buy?
Jun 22 17 Healthcare Stocks Moving In Monday's Pre-Market Session
Jun 22 34 Stocks Moving in Monday's Pre-Market Session
Jun 20 Nabriva strikes out again on FDA nod for fosfomycin
Jun 20 Nabriva Therapeutics Receives Complete Response Letter from FDA on NDA for CONTEPO™ (fosfomycin) for injection
Jun 19 The Daily Biotech Pulse: Tiziana Snags A Patent Win, Decision Day For Nabriva And Evoke, IPOs
Jun 14 The Week Ahead In Biotech: FDA Decisions In The Cards For Merck, Epizyme, Evoke And Ultragenyx
Jun 10 Nabriva Therapeutics (NBRV) Catches Eye: Stock Jumps 11.4%
Jun 8 Nabriva's Shares March Higher, Can It Continue?
Jun 1 Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
Jun 1 Mid-Afternoon Market Update: Dow Gains Over 50 Points; Nabriva Therapeutics Shares Plunge
Jun 1 Implied Volatility Surging for Nabriva (NBRV) Stock Options
May 30 Nabriva secures private $38M capital raise
May 29 Nabriva Therapeutics Announces $38 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
May 29 Nabriva Therapeutics Receives Positive EU CHMP Opinion for XENLETA™ (lefamulin) for the Treatment of Community-Acquired Pneumonia (CAP)
May 29 European advisory group backs Nabriva's lefamulin
May 27 Nabriva Therapeutics to Present at the Jefferies Virtual Healthcare Conference
May 18 National Burden of Macrolide-Resistant Streptococcus Pneumoniae in the United States From Blood and Respiratory Tract Cultures Approaches 40 Percent
May 12 Nabriva Therapeutics plc 2020 Q1 - Results - Earnings Call Presentation
May 12 60 Stocks Moving In Tuesday's Mid-Day Session
May 12 Nabriva Therapeutics Plc (NBRV) CEO Ted Schroeder on Q1 2020 Results - Earnings Call Transcript
May 11 Nabriva Therapeutics EPS beats by $0.02, beats on revenue
May 11 Nabriva Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Updates
May 11 Nabriva Therapeutics to Present at the BofA Securities 2020 Virtual Health Care Conference

Back to the Main NBRV Page...